BlackRock’s Ardent Health ARDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4M Buy
2,176,348
+418,133
+24% +$3.96M ﹤0.01% 3207
2026
Q1
$15.1M Buy
1,758,215
+52,229
+3% +$469K ﹤0.01% 3250
2025
Q4
$15.1M Sell
1,705,986
-6,400
-0.4% -$74K ﹤0.01% 3247
2025
Q3
$22.7M Buy
1,712,386
+365,232
+27% +$4.57M ﹤0.01% 3025
2025
Q2
$18.4M Sell
1,347,154
-103,655
-7% -$1.4M ﹤0.01% 3080
2025
Q1
$19.9M Buy
1,450,809
+808,207
+126% +$11.8M ﹤0.01% 2941
2024
Q4
$11M Buy
642,602
+63,182
+11% +$1.1M ﹤0.01% 3378
2024
Q3
$10.6M Buy
+579,420
New +$10.2M ﹤0.01% 3371

Other funds holding ARDT

BlackRock's ARDT Position: Q2 2026 in Review

BlackRock increased its Ardent Health (ARDT) stake by 24% in Q2 2026, buying an estimated $3.96M and bringing the position to 2,176,348 shares worth $21.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

BlackRock first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $22.7M in Q3 2025. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • BlackRock held 2,176,348 shares of Ardent Health worth $21.4M as of Q2 2026.
  • BlackRock bought 418,133 Ardent Health shares in Q2 2026, an estimated $3.96M.
  • Ardent Health made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3207 holding.
  • BlackRock first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
  • BlackRock's Ardent Health position peaked at $22.7M in Q3 2025.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.